CIBC World Market
BMY.RT

CIBC World Market’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

CIBC World Market’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-74,504
Closed -$51K – 1463
2020
Q4 		$51K Sell
74,504
-1,358
-2% -$2.89K ﹤0.01% 1237
2020
Q3 		$171K Sell
75,862
-657
-0.9% -$1.88K ﹤0.01% 1045
2020
Q2 		$274K Sell
76,519
-11,097
-13% -$40K ﹤0.01% 943
2020
Q1 		$333K Sell
87,616
-1,358
-2% -$4.47K ﹤0.01% 791
2019
Q4 		$268K Buy
+88,974
New +$231K ﹤0.01% 977

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

CIBC World Market's BMY.RT Position: Q1 2021 in Review

CIBC World Market sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 74,504 shares — an estimated $51K sold.

CIBC World Market first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $333K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • CIBC World Market reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • CIBC World Market sold 74,504 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $51K.
  • CIBC World Market first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • CIBC World Market's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $333K in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on CIBC World Market's 13F filing for Q1 2021, filed 11 May 2021.